Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ATPC | Agape Atp | $3.67 | $1.65 | 81.68% | 1.1M | $2.0M | $1.72$128.25 |
| PLYX | Polaryx Therapeutics | $5.97 | $2.45 | 69.60% | 24.4M | $167M | $2.20$48.91 |
| ACXP | Acurx Pharmaceuticals | $2.90 | $0.95 | 48.34% | 31.3M | $5.0M | $1.33$21.00 |
| MGNX | MacroGenics | $3.45 | $1.09 | 45.98% | 477.2K | $149M | $0.99$3.50 |
| TENX | Tenax Therapeutics | $14.57 | $3.55 | 32.21% | 39K | $69M | $4.63$18.38 |
| OCC | Optical Cable | $7.98 | $1.87 | 30.61% | 772K | $54M | $2.40$11.50 |
| FCUV | Focus Universal | $5.59 | $1.23 | 28.13% | 46.8K | $4.3M | $4.13$61.40 |
| INKT | MiNK Therapeutics | $13.37 | $2.92 | 27.94% | 258.7K | $49M | $6.34$76.00 |
| PIII | P3 Health Partners | $3.64 | $0.76 | 26.17% | 887.7K | $9.5M | $1.52$11.30 |
| CRMU | Themes ETF Trust - Leverage Shares 2x Long Crml Daily ETF | $9.55 | $1.95 | 25.72% | 69.6K | - | $6.52$15.25 |
| LFMD | LifeMD | $3.92 | $0.80 | 25.48% | 182K | $150M | $2.56$15.84 |
| BUUU | Buuu Group | $16.50 | $3.24 | 24.42% | 41.3K | $221M | $3.67$20.76 |
| ZNTL | Zentalis Pharmaceuticals | $3.08 | $0.60 | 24.19% | 145K | $179M | $1.01$3.95 |
| VYGR | Voyager Therapeutics | $5.04 | $0.93 | 22.63% | 149.8K | $229M | $2.65$5.55 |
| TKNO | Alpha Teknova | $2.58 | $0.46 | 21.70% | 13.8K | $114M | $1.91$7.48 |
| FIGR | Figure Technology Solutions | $39.59 | $6.95 | 21.29% | 30.7M | $7.0B | $25.00$78.00 |
| ZVRA | Zevra Therapeutics | $11.04 | $1.92 | 21.00% | 305.4K | $513M | $6.19$13.16 |
| SEV | Aptera Motors | $3.82 | $0.66 | 20.89% | 1M | $103M | $1.29$40.85 |
| FGI | Fgi Industries | $4.10 | $0.69 | 20.30% | 22K | $6.5M | $2.28$12.62 |
| LVLU | Lulu's Fashion Lounge | $15.83 | $2.54 | 19.11% | 28.3K | $37M | $2.98$32.32 |
| TTEC | TTEC Holdings | $2.97 | $0.48 | 19.08% | 83.4K | $121M | $1.98$5.60 |
| TBMC | Trailblazer Merger I | $11.81 | $1.86 | 18.70% | 114.1K | $24M | $7.77$14.91 |
| IXHL | Incannex Healthcare | $5.01 | $0.78 | 18.44% | 36K | $49M | $2.40$49.80 |
| YHGJ | Yunhong Green Cti | $3.28 | $0.50 | 17.99% | 46.7K | $7.7M | $2.38$11.50 |
| QTTB | Q32 Bio | $5.99 | $0.89 | 17.45% | 449.9K | $66M | $1.35$6.37 |
| CVV | Cvd Equipment | $4.53 | $0.66 | 17.05% | 117.1K | $27M | $2.46$5.86 |
| LFS | Leifras | $2.65 | $0.38 | 16.74% | 200K | $59M | $1.58$12.49 |
| APPX | Investment Managers Series Trust II - Tradr 2x Long App Daily ETF | $40.67 | -$7.48 | -15.53% | 877.1K | - | $20.21$157.62 |
| HSPTU | Horizon Space Acquisition II Corp. | $7.24 | -$4.37 | -37.64% | 34 | $66M | $7.24$13.50 |
Related Articles
Featured Article
2 Biotech Stocks That Could Make You Richer
James Halley|Jul 14, 2023
These biotech companies are seeing a spike in revenue growth.
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Keith Speights|Mar 19, 2022
Voyager Therapeutics has promising technology. But the stock is very risky.
Parkinson's Disease Patients Get Long-Term Benefits From Experimental Gene Therapy
Cory Renauer|Sep 11, 2020
Three years after treatment with NBIb-1817, Parkinson's disease patients still are still showing improvements.
Is It Too Late to Jump In on Zentalis?
James Halley|Jun 3, 2020
The company's share price has nearly tripled since its IPO less than two months ago. Is it too late to get in on the fun?
Is Now a Good Time To Buy Neurocrine Biosciences?
James Halley|May 14, 2020
The biopharmaceutical company has seen shares rise 44.5% in less than two months.
3 Small-Cap Biotech Stocks That Surged Last Week
Cory Renauer|May 11, 2020
Here's what's behind their impressive market performances.
These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?
David Haen|Apr 23, 2020
These companies just raised significant cash to advance promising drug pipelines.
4 Stocks Battling Breast Cancer
David Haen|Oct 26, 2019
With Breast Cancer Awareness Month drawing to a close and the San Antonio Breast Cancer Symposium on the horizon, stay alert for breaking news from companies developing new treatments.
3 Biotechs That Have Doubled This Year (Acquisition Next?)
Brian Orelli, PhD|Jul 2, 2019
Good news has a way of attracting suitors.
3 Cancer Treatment Stocks to Buy Right Now
Keith Speights, Chuck Saletta, and Todd Campbell|May 23, 2019
These companies could make a big difference in how the disease is diagnosed and treated. And their stocks could make a big difference for long-term investors.
